HCPLive Network

Adopting a Centralized Glucose Management Program Improves Clinical Outcomes in General Hospital Patients with Diabetes

 
By adopting a comprehensive set of case management policies for the care of diabetic and hyperglycemic patients, Johns Hopkins Hospital improved in-hospital mortality rate, reduced length of stay, and reduced hyperglycemia, according to an oral presentation given at the American Diabetes Association 73rd Scientific Sessions in Chicago, IL.
 
The management policies included the ADA policy, which was adopted totally, as well as the institution of a supervisor nurse, computerized order sets and insulin dosing, according to Elias Spanakis, MD, a physician in the division of endocrinology and metabolism at Johns Hopkins.
 
“In the general ward setting in the hospital, we use insulin to control hyperglycemia, we avoid giving pill medications, and sometimes advise patients not to eat,” explained Spanakis.
 
The changes over four years were associated with a 47% reduction in the mortality rate, and a $3,200 decrease in the cost of patient care, said Spanakis, who presented abstract 261-OR, “Impact of a Hospital-Wide Inpatient Glucose Management Program on Economic and Clinical Outcomes in the Non-Critical Care Setting.”


Further Reading
The area of sleep study is only around 30 years old but there are still new advancements that can help improve the daily life of a patient.
As part of the annual meeting of the American College of Chest Physicians new information was rolled out on the "Live Well" Campaign aimed at helping patients with COPD.
AstraZeneca today announced that the US Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes mellitus.
More Reading
The area of sleep study is only around 30 years old but there are still new advancements that can help improve the daily life of a patient.